Cullinan Therapeutics, Inc. (NASDAQ:CGEM) IPO

Cullinan Therapeutics, Inc.

IPO

Went public as Cullinan Management, Inc. Priced at US$21.00 a share on Jan 7, 2021.

Price
US$21.00 a share
Shares offered
11,900,000 shares of common stock
Offering size
US$249.9 million
Underwriters' option
Up to 1,785,000 more shares
Underwriters
MORGAN STANLEY, SVB LEERINK, EVERCORE ISI, H.C. WAINWRIGHT & CO. · In the order on the cover
Shares delivered
On or about Jan 12, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceNov 2, 2020
Filed publiclyDec 18, 2020
Amended 3 timesNewest Jan 6, 2021
Shares registered with an exchangeJan 6, 2021
Declared effective by the SECJan 7, 2021
Final prospectus, with the priceJan 11, 2021

From the cover of the final prospectus (424B4) filed Jan 11, 2021